Comparative In vitro Evaluation of some Commercial Brands of Ramipril Tablets Marketed in India

  • Gokulan P D Sri Vijay Vidyalaya College of Pharmacy, Dharmapuri. Tamilnadu
  • Senthilkumar K L Sri Vijay Vidyalaya College of Pharmacy, Dharmapuri. Tamilnadu
  • Vasanthan V Sri Vijay Vidyalaya College of Pharmacy, Dharmapuri. Tamilnadu
  • Suresh V Sri Vijay Vidyalaya College of Pharmacy, Dharmapuri. Tamilnadu
  • Venkateshwaran Sri Vijay Vidyalaya College of Pharmacy, Dharmapuri. Tamilnadu
  • Komathi A Sri Vijay Vidyalaya College of Pharmacy, Dharmapuri. Tamilnadu
  • Manjushree K Sri Vijay Vidyalaya College of Pharmacy, Dharmapuri. Tamilnadu
  • Thilagavathi T Sri Vijay Vidyalaya College of Pharmacy, Dharmapuri. Tamilnadu

Abstract

The availability of several brands of Ramipril tablets in Indian pharmacies now poses a generic replacement concern for doctors. The goal of this study was to evaluate and compare different brands of Ramipril manufactured by various Indian pharmaceutical businesses under various trade names in order to reduce health risks and ensure the safety of local residents. General quality assessments of these tablets, such as diameter, thickness, hardness, weight variation, friability, disintegration, and dissolution tests, were also carried out according to recognised protocols, with test results falling within the acceptable range. Active components were measured using an approved UV spectrophotometric technique. This type of research is useful for determining the idealness of commercial products.

Keywords: Ramipril, In vitro evaluation, Dissolution study, Disintegration test

References

1. Depalmo Galli Angeli and Carlo Trezza. Quality and stability of ramipril generics/copies versus reference ramipril (Tritace): a 3-month stability comparative study, Clin Drug Investig. 2009; 29(10): 667-76.
2. M. Hareesh reddy and Dr. Sambasiva Rao. A comprehensive review of pharmacological and Therapeutical activities of Anti- hypertensive drug Ramipril, Hyderabad. IAJPS 2017; 4 (11), 3951-3953.
3. Pilote L, Abrahamowicz M, Behlouli H, Eisenberg M, Humphries K, Tu jv 2008 Effect of different angiotensin- converting –enzyme inhibitors on mortality among elderly patients with congestive heart failure”. CMAJ. 2008; 178 (10); 1306-12.
4. Remuzzi, Giuseppe, Prevention and Treatment of Diabetic Renal Disease in Type 2 Diabetes: The BENEDICT study”. Journal of the American Society of Nephrology. 2006; 2.14 (5): 590-597.
5. Peters DH, Frampton JE, “Ramipril, an updated review of its Therapeutic use in essential hypertension and heart failure”. Drugs. 1995; 49 (3):440-66.
6. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The acute infarction ramipril efficiency (AIRE) study investigators”. Lancet. 342 (8875)
7. Yusuf S, Teo KK, Pogue J, et al. Telmisatran, ramipril, or both in patients at high risk for vascular events”. N. Engl. J.Med.2008; 356 (15):1547-59.
8. Kotake T, Kosugi S, Takimoto T, Nakata S, Shiga J, Nagate Y, Nakagawa T, Take H, Katagiri S, Intravascular large B-cell lymphoma presenting pulmonary arterial hypertension as an initial manifestation. Intern Med 2010; 49:51–54.
9. Snyder LS, Harmon KR, Estensen RD. Intravascular lymphomatosis (malignant angioendotheliomatosis) presenting as pulmonary hypertension. Chest 1989; 96:1199–1200.
10. Owa M, Koyama J, Asakawa K, Hikita H, Kubo K, Ikeda S, Intravascular lymphomatosis presenting as reversible severe pulmonary hypertension. Int J Cardiol 2000; 75:283–284.
11. Von Herbay A, Illes A, Waldherr R, Otto HF. Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer 1990; 66:587–592
12. Saleem M, Shahin M, Srinivas B, Begum A. Evaluation of tablets by friability apparatus. Int. J. Res. Pharm. Chem.2014; 4(4): 837-840.
13. Oishi TS, Nimmi I, Islam SMA. Comparative in vitro Bioequivalence Analysis of Some Generic Tablets of Atorvastatin, a BCS Class II Compound. Bangladesh Pharm. J. 2011; 14(1): 61-66.
14. Kumar P, Ganure AL, Subudhi BB, Shukla S, Upadhyay P.Design and comparative in-vitro and in-vivo evaluation of starchacrylate graft copolymer based salbutamol sulphate sustained release tablets. Asian J. Pharm. Sci. 2015; 10(3):239-246.
15. Nayak AK, Pal D. Comparative in vitro Bioequivalence Analysis of Some Ciprofloxacin HCl Generic Tablets. Int. J. Pharm. Sci. Res. 2010; 1(8): 51-57.
16. Mangal M, Thakral S, Goswami M, Thakur N. Comparative study between various reported disintegration methods for fast dissolving tablets. African J. Basic & Appl. Sci. 2012; 4(4): 106-109.
17. Abbirami V, Sainithya P, Shobana A, Devi DR, Hari BNV. Review on In-vitro bioequivalence Studies and its Methodologies. Int. J. Chem.Tech. Res. 2013; 5(5): 2295-2302.
Statistics
78 Views | 71 Downloads
How to Cite
Gokulan P D, Senthilkumar K L, Vasanthan V, Suresh V, Venkateshwaran, Komathi A, Manjushree K, and Thilagavathi T. “Comparative In Vitro Evaluation of Some Commercial Brands of Ramipril Tablets Marketed in India”. Current Research in Pharmaceutical Sciences, Vol. 12, no. 1, Apr. 2022, pp. 32-39, doi:10.24092/CRPS.2022.120105.
Section
Research Articles

Most read articles by the same author(s)